Home » Healthcare » Donor Egg IVF Market

Donor Egg IVF Market By Cycle Type (Fresh Donor Egg IVF Cycle, Frozen Donor Egg IVF Cycle); By Pricing Model (Pay-Per-Cycle, Bundled Package); By Age Group (21-35 Years, 36-40 Years, 41-45 Years); By End User (Fertility Clinics, Hospitals, Surgical Centers, Others); By Region – Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032

Price: $4699

Published: | Report ID: 48687 | Report Format : PDF
REPORT ATTRIBUTE DETAILS
Historical Period 2019-2022
Base Year 2023
Forecast Period 2024-2032
Donor Egg IVF In Vitro Fertilization Market Size 2023 USD 2860 million
Donor Egg IVF In Vitro Fertilization Market, CAGR 9.00%
Donor Egg IVF In Vitro Fertilization Market Size 2032 USD 5698.73 million

Market Overview

The Donor Egg IVF In Vitro Fertilization Market is projected to grow from USD 2860 million in 2023 to an estimated USD 5698.73 million by 2032, reflecting a compound annual growth rate (CAGR) of 9.00% from 2024 to 2032. This growth is primarily driven by the increasing prevalence of infertility, advancements in assisted reproductive technology (ART), and the growing acceptance of IVF procedures globally. The Donor Egg IVF In Vitro Fertilization Market is witnessing significant growth, fueled by evolving societal trends and technological advancements. Key market drivers include an increasing number of older couples seeking conception, a shift in family planning trends, and advancements in IVF technologies, which enhance success rates and patient outcomes. Additionally, the growing demand for personalized and customized fertility treatments aligns with consumer preferences, further supporting market growth. The integration of AI and machine learning into fertility treatment protocols and improved cryopreservation techniques are notable trends that enhance the overall efficacy of IVF treatments.

Geographically, North America holds the largest market share in the Donor Egg IVF In Vitro Fertilization Market, owing to the presence of advanced healthcare infrastructure, high awareness about fertility treatments, and increased healthcare spending. Europe follows closely, driven by a similar demand for fertility treatments and supportive regulatory frameworks. The Asia-Pacific region is anticipated to exhibit the highest growth rate, attributed to the rising infertility rates, increasing medical tourism, and expanding healthcare investments. Key players in this market include prominent companies such as Vitrolife AB, Cook Medical LLC, CooperSurgical, Inc., and Merck KGaA, all of which play a vital role in advancing fertility treatment technologies and expanding their geographic presence.

Design Element 2

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

CTA Design Element 3

Market Drivers

Rising Infertility Rates Globally:

One of the primary drivers of the Donor Egg IVF In Vitro Fertilization Market is the increasing prevalence of infertility worldwide. Studies suggest that various factors, including lifestyle changes, delayed childbearing, rising stress levels, and environmental influences, contribute to a significant decline in fertility rates across both developed and developing countries. For instance, according to a report published by the World Health Organization (WHO) in April 2023, around 17.5% of the adult population – roughly 1 in 6 people worldwide – experience infertility. This highlights the urgent need to increase access to affordable, high-quality fertility care for those in need. The prevalence of infertility is comparable across high-, middle-, and low-income countries, indicating that this is a major global health challenge. As couples seek alternative methods to conceive, the demand for IVF treatments using donor eggs grows. This trend is further accelerated by increased awareness regarding infertility treatments, enabling couples to consider IVF with donor eggs as a viable option. The market is particularly driven by women who face age-related infertility challenges, with donor egg IVF providing a solution to help overcome biological limitations associated with older maternal age. Consequently, as infertility rates rise, the demand for donor egg IVF procedures is expected to follow suit.

Technological Advancements in Assisted Reproductive Technologies (ART):

Another significant driver of the market is the continuous evolution of assisted reproductive technologies, which have revolutionized IVF procedures and improved success rates. Technological innovations, including preimplantation genetic testing, enhanced egg freezing techniques, and improved embryo culturing methods, are instrumental in enhancing the efficacy of IVF treatments. For instance, according to the Centers for Disease Control and Prevention (CDC), in 2020, there were 326,468 new ART cycles reported in the United States, resulting in 91,453 pregnancies and 79,942 infants. This demonstrates the significant impact of technological advancements in assisted reproductive technologies on improving success rates and outcomes in IVF treatments. Notably, the development of cryopreservation techniques, such as vitrification, has increased the viability of frozen eggs and embryos, thereby boosting the likelihood of successful pregnancies. Moreover, artificial intelligence (AI) and machine learning tools are increasingly being integrated into fertility treatments, enabling clinics to analyze patient data, predict outcomes, and optimize treatment plans. These technological advancements make donor egg IVF more appealing to prospective parents by increasing the chances of a successful pregnancy, ultimately driving the market’s growth trajectory.

Integrating this with the content:

Changing Family Planning Trends and Increased Acceptance of IVF Procedures: Shifting societal trends and changing perspectives on family planning are also significant contributors to the expansion of the Donor Egg IVF In Vitro Fertilization Market. Many individuals and couples today prioritize career growth and personal goals, often leading to delayed parenthood. Consequently, there is a rising demand for fertility treatments as more people seek to start families later in life. For instance, between 2017 and 2019, 10% of American women aged 15 to 44 reported having received some form of fertility service. This share varies by age and educational attainment, with women aged 35 to 44 being more likely to use these services (18% vs. 7% for those younger than 35). The societal stigma around IVF procedures has notably diminished over the years, thanks to increased public awareness, support from prominent figures, and educational campaigns. As acceptance grows, more people are willing to consider alternative reproductive options like donor egg IVF. Furthermore, the rise of single-parent families and LGBTQ+ couples opting for donor egg IVF treatments has diversified the patient demographic, expanding the market’s scope. This trend toward acceptance and inclusivity significantly contributes to the steady increase in demand for these procedures.

Favorable Government Policies and Insurance Coverage for Fertility Treatments:

Supportive government policies and insurance coverages are pivotal factors driving the Donor Egg IVF In Vitro Fertilization Market. Several countries have introduced policies to assist couples seeking fertility treatments, either through direct financial support, tax benefits, or subsidies on treatment costs. For example, countries with high fertility treatment costs, such as the United States, have observed an increase in states mandating insurance coverage for IVF procedures. These initiatives ease the financial burden on patients and make IVF treatments more accessible to a broader audience. Additionally, as countries recognize the economic and societal impact of declining birth rates, some governments have implemented programs to encourage family planning and offer support to couples facing infertility issues. These favorable policies, coupled with the introduction of insurance coverage for IVF treatments, are expected to drive demand for donor egg IVF procedures, thereby promoting market growth.

Market Trends

Integrating this with the content:

Integration of Advanced Technologies in Fertility Clinics: A prominent trend within the Donor Egg IVF In Vitro Fertilization Market is the integration of advanced technologies to enhance treatment outcomes and efficiency. Innovations like artificial intelligence (AI) and machine learning are increasingly utilized to predict IVF success rates and assist in embryo selection. These technologies allow fertility specialists to analyze vast datasets, helping them to make informed decisions and tailor treatments to individual patients, ultimately increasing the likelihood of successful pregnancies. For instance, based on CDC’s 2021 Fertility Clinic Success Rates Report, approximately 238,126 patients had 413,776 ART cycles performed at 453 reporting clinics in the United States during 2021, resulting in 91,906 live births (deliveries of one or more living infants) and 97,128 live born infants. This demonstrates the significant impact of advanced technologies in fertility clinics on improving treatment outcomes and efficiency. Additionally, preimplantation genetic testing (PGT) has become a standard offering in many fertility clinics, enabling doctors to screen embryos for chromosomal abnormalities before implantation. This testing improves success rates and reduces the risk of genetic disorders. Advanced cryopreservation techniques, such as vitrification, are also becoming widespread, providing patients with more reliable options for egg and embryo freezing. Such innovations not only improve patient outcomes but also make the overall process more efficient, allowing clinics to cater to an expanding patient base.

Growing Acceptance of Non-Traditional Families and Increasing Demand Among LGBTQ+ and Single Parents:

Another notable trend driving growth in the Donor Egg IVF In Vitro Fertilization Market is the increasing demand from non-traditional families, including LGBTQ+ couples and single parents. With shifting societal norms and more inclusive laws surrounding parenthood, there is a growing number of LGBTQ+ individuals and single people opting to have children through donor egg IVF. This trend has led fertility clinics to diversify their services, with many clinics now offering customized treatments and counseling tailored to meet the unique needs of these patient groups. As societal acceptance of diverse family structures expands, the market is also seeing a rise in fertility tourism, where patients travel to countries with more accommodating fertility laws and advanced treatment facilities. This trend is expected to continue as awareness and acceptance grow, along with the support of influential advocates and policymakers working to make reproductive treatments accessible to all. These developments are driving significant growth in the donor egg IVF market, reflecting a broader, more inclusive approach to family planning.

Market Restraints and Challenges

High Cost of Treatment and Limited Insurance Coverage:

One of the primary challenges in the Donor Egg IVF In Vitro Fertilization Market is the high cost associated with IVF treatments using donor eggs. Costs can range from $20,000 to $50,000 per cycle, depending on the clinic and geographic location, making these treatments financially inaccessible for many individuals and couples. While some countries offer insurance coverage or subsidies for IVF, coverage is often limited and varies widely by region. In countries like the United States, where coverage is not universally mandated, patients frequently face out-of-pocket expenses, leading to financial strain. This cost barrier significantly limits market expansion, as a large segment of the population may be unable or unwilling to invest in these expensive treatments. Consequently, the lack of widespread insurance coverage and high treatment costs remain critical obstacles to market growth.

Ethical and Legal Challenges Surrounding Donor Egg IVF:

The Donor Egg IVF In Vitro Fertilization Market also faces ethical and legal challenges that can restrict market potential. Ethical concerns regarding the commercialization of donor eggs, the rights of donors, and the welfare of donor-conceived children often spark debates, influencing regulatory policies and societal perceptions. In some countries, restrictive laws limit or prohibit the use of donor eggs for IVF, thereby reducing market opportunities. For example, in regions where anonymity for egg donors is mandated, patients may face limited options, leading to delays in treatment. Additionally, cultural and religious beliefs in certain areas may view egg donation unfavorably, creating a barrier for individuals who may otherwise consider this option. These legal and ethical considerations complicate market dynamics, as varying regulations across countries impact the availability and acceptance of donor egg IVF procedures. These challenges underscore the need for regulatory clarity and international standards to support market expansion.

Market Segmentation Analysis

By Cycle Type

The market is primarily divided into two cycle types: fresh donor egg IVF cycles and frozen donor egg IVF cycles. In fresh donor egg IVF cycles, donor eggs are retrieved, fertilized, and transferred in the same cycle, leading to higher success rates due to the immediacy of the procedure. This segment has traditionally been the preferred option for patients seeking optimal success rates. However, fresh cycles are more complex logistically and require precise timing, making them relatively expensive. Fresh cycles have historically contributed significantly to the market, given their perceived higher effectiveness. In contrast, frozen donor egg IVF cycles have gained substantial traction due to advancements in cryopreservation technology, particularly the vitrification method. Frozen cycles offer greater flexibility and convenience, allowing patients to select donor eggs from egg banks and proceed with the cycle at their convenience. Additionally, frozen egg cycles are generally more cost-effective than fresh cycles, broadening accessibility for patients who might otherwise be unable to afford IVF treatments. Given the increasing reliability of frozen cycles and the enhanced availability of donor eggs, this segment is expected to grow at a faster rate over the forecast period. As fertility clinics continue to refine cryopreservation techniques, the frozen donor egg IVF cycle segment is poised to capture a significant market share.

By Pricing Model

The market can also be analyzed based on pricing models, specifically the pay-per-cycle model and the bundled package model. In the pay-per-cycle model, patients pay a fee for each IVF cycle they undergo, which allows for cost flexibility and the option to pay as they progress through the treatment. This model is particularly appealing to patients seeking single cycles or who are hesitant to commit to multiple cycles upfront. However, because IVF success rates can vary, patients may face financial uncertainty with this model if multiple cycles are required. While this model is straightforward and commonly used, its cost can quickly accumulate for patients who need several cycles to achieve successful outcomes. The bundled package model, on the other hand, offers patients a set price for multiple IVF cycles, often with a partial or full refund guarantee if treatment is unsuccessful. This model has gained popularity among patients seeking financial predictability and peace of mind. Bundled packages typically cover additional cycles at a discounted rate, making the overall treatment more affordable for those needing multiple attempts. Clinics offering bundled packages often include complementary services such as counseling and genetic testing, enhancing the value proposition for patients. As demand for accessible fertility treatment rises, bundled packages are expected to drive significant growth within the donor egg IVF market, appealing to patients looking for more cost-effective solutions in the long term.

Segments

Based on Cycle Type

  • Fresh Donor Egg IVF Cycle
  • Frozen Donor Egg IVF Cycle

Based on Pricing Model

  • Pay-Per-Cycle
  • Bundled Package

Based on Age Group

  • 21-35 Years
  • 36-40 Years
  • 41-45 Years

Based on End User

  • Fertility Clinics
  • Hospitals
  • Surgical Centers
  • Others

Based on Region

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • South-east Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Argentina
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa

Regional Analysis

North America (35%):

North America holds the largest market share, accounting for approximately 35% of the global market. This dominance can be attributed to well-established healthcare infrastructure, high awareness of fertility treatments, and a favorable regulatory environment. The United States leads this region, with a strong presence of advanced fertility clinics and specialized centers offering donor egg IVF treatments. Additionally, rising infertility rates, coupled with increasing insurance coverage for IVF procedures in select states, have driven market growth. Canada also contributes to regional growth due to government support for fertility treatments and a relatively progressive stance on assisted reproductive technologies. Overall, North America is expected to maintain its lead, supported by technological advancements and growing demand among individuals and couples seeking fertility solutions.

Europe (30%):

Europe is the second-largest market, capturing around 30% of the global share. Countries such as the United Kingdom, Spain, and Denmark play a central role in the region’s growth, driven by supportive regulatory frameworks and favorable reimbursement policies. Spain, in particular, is recognized as a hub for fertility tourism, attracting international patients due to its progressive laws and availability of high-quality fertility services. The European market is also influenced by cultural acceptance of fertility treatments, which varies across countries. Western Europe remains the dominant sub-region, while Eastern Europe exhibits steady growth due to increasing investment in healthcare and rising demand for IVF services. Overall, Europe is anticipated to witness sustained growth, bolstered by supportive policies and increased patient awareness.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Key players

  • Beverly Hills Egg Donation
  • Donor Egg Bank USA
  • Egg Donor America
  • MyEggBank
  • Extraordinary Conceptions LLC
  • Premier Egg Donors
  • California Fertility Partners
  • Extend Fertility
  • Boston IVF
  • Fairfax EggBank
  • Virtus Health
  • OvaScience
  • CooperSurgical
  • IVIRMA Global
  • Indira IVF
  • Cloudnine Fertility
  • London Women’s Clinic
  • IVF NAMBA Clinic
  • Shanghai United Family Hospital
  • Columbia University Fertility Center

Competitive Analysis

The Donor Egg IVF In Vitro Fertilization Market is highly competitive, with a diverse array of key players, including specialized egg donation agencies, established fertility clinics, and international healthcare providers. Companies such as Beverly Hills Egg Donation, Donor Egg Bank USA, and Fairfax EggBank specialize in donor egg banking, offering a range of options to meet diverse patient needs. Meanwhile, comprehensive fertility clinics like Boston IVF, CooperSurgical, and Columbia University Fertility Center provide end-to-end fertility services, from initial consultations to post-treatment support, allowing them to capture a broader market share. International players like IVIRMA Global and Virtus Health expand their footprint through strategic partnerships and technology integration, enhancing treatment accessibility and quality. In emerging markets, companies like Indira IVF and Cloudnine Fertility leverage local expertise and cost advantages to cater to a growing demand for affordable IVF solutions. This competitive landscape is characterized by continuous innovation, expansion, and a commitment to personalized patient care.

Recent Developments

  • In June 2021, MyEggBank launched a rebranding campaign “This is Who We Are” and expanded services with the Synchronous Egg Donor Program.
  • In May 2021, InTandem Capital Partners completed a growth equity investment in Reproductive Partners Medical Group and Fertility Centers of Orange County.

Market Concentration and Characteristics 

The Donor Egg IVF In Vitro Fertilization Market is moderately fragmented, with a mix of specialized egg donation agencies, large-scale fertility clinics, and multinational healthcare providers contributing to its structure. While no single player dominates the market, several prominent companies, such as CooperSurgical, Boston IVF, and IVIRMA Global, hold significant shares due to their extensive service offerings, advanced technological integration, and expansive geographic presence. The market is characterized by rapid technological advancements, such as AI-driven embryo selection and improved cryopreservation techniques, which enhance the success rates of IVF treatments. Additionally, a strong focus on personalized patient care and comprehensive fertility solutions defines the market, as providers strive to meet diverse patient needs. Growth is further fueled by increased awareness of fertility treatments, rising infertility rates, and shifting societal acceptance of assisted reproductive technologies. Despite regional regulatory variations, the market is expected to continue expanding as fertility treatments become more widely accepted and accessible globally.

Report Coverage

The research report offers an in-depth analysis based on Cycle Type, Pricing Model, Age Group, End User and Region. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.

Future Outlook

  1. Ongoing innovations in cryopreservation and AI-driven embryo selection are expected to enhance success rates, attracting more patients to donor egg IVF treatments.
  1. Increasing global infertility rates, driven by lifestyle factors and delayed parenthood, will continue to drive demand for donor egg IVF procedures.
  1. Countries with advanced healthcare facilities and lower treatment costs, such as India and Spain, will see a rise in fertility tourism, boosting market growth.
  1. As societal norms evolve, a greater number of single parents and LGBTQ+ couples will seek donor egg IVF, broadening the market’s customer base.
  1. Clinics are expected to increasingly offer tailored fertility treatment plans, including genetic testing and counseling services, to improve patient satisfaction and outcomes.
  1. Major fertility providers will likely expand their presence into emerging markets, particularly in the Asia-Pacific and Latin America regions, to tap into rising demand.
  1. Countries are anticipated to implement more supportive policies, such as insurance mandates for fertility treatments, making donor egg IVF more financially accessible.
  1. Innovations in preimplantation genetic testing will allow for more comprehensive screening, improving embryo selection and reducing the likelihood of genetic disorders.
  1. As awareness of fertility preservation options grows, more women will opt to freeze eggs for future use, expanding the market for donor egg banking services.
  1. The market may experience consolidation as larger players acquire specialized clinics and egg banks, enhancing service offerings and operational efficiency on a global scale.

1. Introduction
1.1. Report Description
1.2. Purpose of the Report
1.3. USP & Key Offerings
1.4. Key Benefits for Stakeholders
1.5. Target Audience
1.6. Report Scope
1.7. Regional Scope

2. Scope and Methodology
2.1. Objectives of the Study
2.2. Stakeholders
2.3. Data Sources
2.3.1. Primary Sources
2.3.2. Secondary Sources
2.4. Market Estimation
2.4.1. Bottom-Up Approach
2.4.2. Top-Down Approach
2.5. Forecasting Methodology

3. Executive Summary

4. Global Donor Egg IVF In Vitro Fertilization Market
4.1. Market Overview
4.2. Market Performance
4.3. Impact of COVID-19
4.4. Market Forecast

5. Market Segmentation by Cycle Type
5.1. Fresh Donor Egg IVF Cycle
5.1.1. Market Trends
5.1.2. Market Forecast
5.1.3. Revenue Share
5.1.4. Revenue Growth Opportunity
5.2. Frozen Donor Egg IVF Cycle
5.2.1. Market Trends
5.2.2. Market Forecast
5.2.3. Revenue Share
5.2.4. Revenue Growth Opportunity

6. Market Segmentation by Pricing Model
6.1. Pay-Per-Cycle
6.1.1. Market Trends
6.1.2. Market Forecast
6.1.3. Revenue Share
6.1.4. Revenue Growth Opportunity
6.2. Bundled Package
6.2.1. Market Trends
6.2.2. Market Forecast
6.2.3. Revenue Share
6.2.4. Revenue Growth Opportunity

7. Market Segmentation by Age Group
7.1. 21-35 Years
7.1.1. Market Trends
7.1.2. Market Forecast
7.1.3. Revenue Share
7.1.4. Revenue Growth Opportunity
7.2. 36-40 Years
7.2.1. Market Trends
7.2.2. Market Forecast
7.2.3. Revenue Share
7.2.4. Revenue Growth Opportunity
7.3. 41-45 Years
7.3.1. Market Trends
7.3.2. Market Forecast
7.3.3. Revenue Share
7.3.4. Revenue Growth Opportunity

8. Market Segmentation by End User
8.1. Fertility Clinics
8.1.1. Market Trends
8.1.2. Market Forecast
8.1.3. Revenue Share
8.1.4. Revenue Growth Opportunity
8.2. Hospitals
8.2.1. Market Trends
8.2.2. Market Forecast
8.2.3. Revenue Share
8.2.4. Revenue Growth Opportunity
8.3. Surgical Centers
8.3.1. Market Trends
8.3.2. Market Forecast
8.3.3. Revenue Share
8.3.4. Revenue Growth Opportunity
8.4. Others
8.4.1. Market Trends
8.4.2. Market Forecast
8.4.3. Revenue Share
8.4.4. Revenue Growth Opportunity

9. Market Breakup by Region
9.1. North America
9.1.1. United States
9.1.1.1. Market Trends
9.1.1.2. Market Forecast
9.1.2. Canada
9.1.2.1. Market Trends
9.1.2.2. Market Forecast
9.2. Asia-Pacific
9.2.1. China
9.2.2. Japan
9.2.3. India
9.2.4. South Korea
9.2.5. Australia
9.2.6. Indonesia
9.2.7. Others
9.3. Europe
9.3.1. Germany
9.3.2. France
9.3.3. United Kingdom
9.3.4. Italy
9.3.5. Spain
9.3.6. Russia
9.3.7. Others
9.4. Latin America
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Others
9.5. Middle East and Africa
9.5.1. Market Trends
9.5.2. Market Breakup by Country
9.5.3. Market Forecast

10. SWOT Analysis
10.1. Overview
10.2. Strengths
10.3. Weaknesses
10.4. Opportunities
10.5. Threats

11. Value Chain Analysis

12. Porters Five Forces Analysis
12.1. Overview
12.2. Bargaining Power of Buyers
12.3. Bargaining Power of Suppliers
12.4. Degree of Competition
12.5. Threat of New Entrants
12.6. Threat of Substitutes

13. Price Analysis

14. Competitive Landscape
14.1. Market Structure
14.2. Key Players
14.3. Profiles of Key Players
14.3.1. Beverly Hills Egg Donation
14.3.1.1. Company Overview
14.3.1.2. Product Portfolio
14.3.1.3. Financials
14.3.1.4. SWOT Analysis
14.3.2. Donor Egg Bank USA
14.3.3. Egg Donor America
14.3.4. MyEggBank
14.3.5. Extraordinary Conceptions LLC
14.3.6. Premier Egg Donors
14.3.7. California Fertility Partners
14.3.8. Extend Fertility
14.3.9. Boston IVF
14.3.10. Fairfax EggBank
14.3.11. Virtus Health
14.3.12. OvaScience
14.3.13. CooperSurgical
14.3.14. IVIRMA Global
14.3.15. Indira IVF
14.3.16. Cloudnine Fertility
14.3.17. London Women’s Clinic
14.3.18. IVF NAMBA Clinic
14.3.19. Shanghai United Family Hospital
14.3.20. Columbia University Fertility Center

15. Research Methodology

Frequently Asked Questions:

What is the current size of the Donor Egg IVF Market?

The Donor Egg IVF In Vitro Fertilization Market is projected to grow from USD 2860 million in 2023 to an estimated USD 5698.73 million by 2032, reflecting a compound annual growth rate (CAGR) of 9.00% from 2024 to 2032.

What factors are driving the growth of the Donor Egg IVF Market?

Rising prevalence of infertility Influenced by lifestyle changes such as delayed childbearing, increased stress levels, and exposure to environmental toxins. Conditions like polycystic ovary syndrome (PCOS) and endometriosis contribute to the growing demand for donor egg IVF services. Improved egg retrieval techniques, embryo culture, and preimplantation genetic testing (PGT) have significantly enhanced the success rates of IVF procedures.

What are some challenges faced by the Donor Egg IVF Market?

A: The expenses involved in donor egg IVF procedures can be prohibitive for many patients. Lack of information and education about infertility treatments hinders market expansion. The invasive nature of egg retrieval and stringent screening requirements limit the pool of eligible donors. Resistance due to cultural, religious, or social beliefs can prevent individuals from seeking treatment.

Who are the major players in the Donor Egg IVF Market?

Major Players in the Donor Egg IVF Market are The Cape Fertility Clinic, Medfem Fertility Clinic. Beacon CARE Fertility, Merrion Fertility Clinic, The Montreal Fertility Center, Shanghai United Family Hospital, Morpheus Life Sciences Pvt. Ltd., KL Fertility & Gynecology Centre, Bourn Hall Fertility Center, TMC Fertility Centre.

Which segment is leading the market share?

Frozen donor egg cycles are gaining popularity due to their flexibility and cost-effectiveness, making them a leading segment in the market.

Donor Egg IVF Treatment Market

Published:
Report ID: 5402

Medical Bionic Implant and Artificial Organs Market

Published:
Report ID: 63646

Tissue banking Market

Published:
Report ID: 11330

Primary Cell Culture Market

Published:
Report ID: 53053

Egypt In-Vitro Fertilization (IVF) Market

Published:
Report ID: 38526

Skin Substitutes Market

Published:
Report ID: 36831

India Bone Marrow Transplantation (BMT) Market

Published:
Report ID: 35571

Gift Cards Market

Published:
Report ID: 6518

Feed Mycotoxin Detoxifiers Market

Published:
Report ID: 74902

Healthcare Companion Robots Market

Published:
Report ID: 74875

Hepatitis B Diagnostic Test Market

Published:
Report ID: 74850

Helicobacter Pylori Testing Market

Published:
Report ID: 22484

Blood Pressure Transducers Market

Published:
Report ID: 74690

Periodontal Disease Market

Published:
Report ID: 64532

Cocaine Intoxication Treatment Market

Published:
Report ID: 3673

Vascular Dementia Treatment Market

Published:
Report ID: 74473

Thrombocytopenia Treatment Market

Published:
Report ID: 74455

Cold Disposable Biopsy Forceps Market

Published:
Report ID: 74398

Cloud-Based Drug Discovery Platform Market

Published:
Report ID: 74389

Clinical Documentation Improvement Market

Published:
Report ID: 74359

Purchase Options

The report comes as a view-only PDF document, optimized for individual clients. This version is recommended for personal digital use and does not allow printing.
$4699

To meet the needs of modern corporate teams, our report comes in two formats: a printable PDF and a data-rich Excel sheet. This package is optimized for internal analysis and multi-location access, making it an excellent choice for organizations with distributed workforce.
$5699

The report will be delivered in printable PDF format along with the report’s data Excel sheet. This license offers 100 Free Analyst hours where the client can utilize Credence Research Inc.’s research team. It is highly recommended for organizations seeking to execute short, customized research projects related to the scope of the purchased report.
$7699

Smallform of Sample request

Have a question?

User Profile

Don’t settle for less – trust Mitul to help you find the best solution.

Report delivery within 24 to 48 hours

– Other Info –

What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –


support

24/7 Research Support


– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

– Trusted By –

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN